Investing.com - Financial Markets Worldwide

Laboratorios Richmond SACIF (RICHm)

Buenos Aires
Currency in ARS
1,355.000
-5.000(-0.37%)
Delayed Data·

RICHm Financial Summary

Key Ratios

P/E Ratio6.43
Price/Book1.6
Debt / Equity215.52%
Return on Equity32.03%
Dividend Yield1.98%
EBITDA20.08B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa9,330.2132,366.1957,517.8584,989.4291,794.14
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa4,546.759,601.527,177.8544,756.5350,236.58
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,328.524,491.759,242.5411,539.115,565.24
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa733.941,152.13508.94-23,629.3323,845.09
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa12,937.0350,048.5126,805.52337,324.2260,152.99
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa5,358.9118,166.7628,132.9479,061.0556,835.5
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa5,202.1310,471.3631,817.8349,982.465,349.02
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-1,321.78-7,331.82-33,355.24-17,614.17-3,857.54
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-181.337,273.52-13,345.56-4,544.395,622.61
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,064.99-11,756.9-23,181.36-28,247.16-8,945.09
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa1,701.8217,773.064,079.1320,141.6312,464.83
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa347.1712,784.31-36,269.17-16,448.38,173.12
* In Millions of ARS (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 232.64%
Dividend Yield
1.98%
Industry Median 2.83%
Annualised payout
26.89
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
70.15 / --
Revenue / Forecast
27.02B / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Laboratorios Richmond's earnings for the latest quarter?

The Laboratorios Richmond EPS (TTM) is 232.64. Laboratorios Richmond reported sales of 27,017.91, net income of 5,665.09, and EPS of 70.15 for the latest quarter.

What was Laboratorios Richmond's net income for the latest quarter?

Laboratorios Richmond's net income for the latest quarter was 5,665.09.

How did Laboratorios Richmond's performance compare year-over-year in the latest quarter?

The company's revenue moved from 33,953.97 in the previous quarter to 27,017.91 in the latest quarter, and net income moved from 5,832.22 to 5,665.09 compared to the previous quarter.

What is Laboratorios Richmond's net profit margin on a TTM basis?

Laboratorios Richmond's trailing twelve months (TTM) net profit margin is 25.98%.

How does Laboratorios Richmond's debt to equity ratio compare to industry standards?

Laboratorios Richmond's total debt-to-equity ratio is 215.52%.

What is Laboratorios Richmond's return on investment on a TTM basis?

Laboratorios Richmond's trailing twelve months (TTM) return on investment (ROI) is 32.03%.

Did Laboratorios Richmond gain or lose cash last quarter?

In the latest quarter, Laboratorios Richmond's net change in cash was -6,309.41 million.

What were Laboratorios Richmond's total assets and liabilities in the latest quarter?

As of the latest quarter, Laboratorios Richmond reported total assets of 295,133.73 million and total liabilities of 67,529.16 million.

How has Laboratorios Richmond's total revenue grown this year?

Laboratorios Richmond's total revenue was 33,953.97 in the previous quarter and 27,017.91 in the latest quarter.

What is Laboratorios Richmond's gross margin on a TTM basis?

Laboratorios Richmond's trailing twelve months (TTM) gross margin is 55.30%.

What was Laboratorios Richmond's revenue per share for the latest quarter?

Laboratorios Richmond's revenue per share for the latest quarter was 46.86.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.